These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1347540)

  • 1. Glycosylation of proteins and microangiopathy.
    Brownlee M
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():46-50. PubMed ID: 1347540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
    Soulis-Liparota T; Cooper M; Papazoglou D; Clarke B; Jerums G
    Diabetes; 1991 Oct; 40(10):1328-34. PubMed ID: 1834497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?
    Winegrad AI
    Diabetes; 1987 Mar; 36(3):396-406. PubMed ID: 3026877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aminoguanidine].
    Kawano M; Kawakami M
    Nihon Rinsho; 1997 Nov; 55 Suppl():221-4. PubMed ID: 9434471
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminoguanidine prevents sorbitol accumulation, nonenzymatic protein glycosylation and development of kidney lesions in diabetic rats.
    Kumari K; Murthy PS; Sahib MK
    Experientia; 1991 Mar; 47(3):252-4. PubMed ID: 2009934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy.
    Greene DA; Lattimer SA
    Ann N Y Acad Sci; 1986; 488():334-40. PubMed ID: 3034118
    [No Abstract]   [Full Text] [Related]  

  • 8. Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats.
    Wada R; Sugo M; Nakano M; Yagihashi S
    Diabetologia; 1999 Jun; 42(6):743-7. PubMed ID: 10382595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoguanidine and diabetic neuropathy.
    Monnier VM
    Eur J Endocrinol; 1996 Apr; 134(4):398-400. PubMed ID: 8640283
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoguanidine, a potential drug for the treatment of diabetic complications.
    Wolffenbuttel BH; Huijberts MS
    Neth J Med; 1993 Jun; 42(5-6):205-8. PubMed ID: 8377878
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA; Chakrabarti S; Lattimer SA; Sima AA
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
    Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
    J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA
    Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
    Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
    Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
    Greene DA; Lattimer SA; Sima AA
    N Engl J Med; 1987 Mar; 316(10):599-606. PubMed ID: 3027558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A; Mistry K; Diecke FP; Cruz E
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonenzymatic glycosylation of macromolecules. Prospects of pharmacologic modulation.
    Brownlee M
    Diabetes; 1992 Oct; 41 Suppl 2():57-60. PubMed ID: 1526337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic microangiopathy--its biochemical bases].
    Kawazu S; Tomono S
    Nihon Rinsho; 1991 Feb; 49 Suppl():34-42. PubMed ID: 1827848
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic and ultrastructural aspects of experimental diabetic glomerulopathy.
    Martino G; Botte L; Gualà L; Covello C
    J Endocrinol Invest; 1986 Apr; 9(2):87-95. PubMed ID: 3011887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.